Home Research Feeds Characteristics of functional constipation and analysis of intestinal microbiota in children aged 0-4 in Zunyi region

Characteristics of functional constipation and analysis of intestinal microbiota in children aged 0-4 in Zunyi regionOriginal paper

Researched by:

  • Karen Pendergrass

Last Updated: 2026-07-04

Karen Pendergrass
Karen Pendergrass

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.

Read More
Location
China
Sample Site
Feces
Species
Homo sapiens

What was studied?

Researchers examined the prevalence of functional constipation (FC) and associated gut microbiota patterns in children aged 0 to 4 years in the Zunyi region of China.

How was it studied?

From October to December 2023, 2039 children were surveyed using stratified sampling and a Rome IV based questionnaire. Twenty nine children with FC and 26 age, sex, and area matched healthy controls were then compared for gut microbiota composition.

What did they find?

FC prevalence was 7.4% (151 of 2039), with no significant difference between boys (6.6%) and girls (8.5%). The FC group showed higher gut microbial richness and diversity, with greater relative abundance of Firmicutes, Actinobacteria, and Proteobacteria than controls.

Why it matters

The findings suggest FC in young children is common and linked to measurable shifts in gut microbiota composition rather than to sex, pointing toward the microbiome as a factor worth further study in pediatric constipation.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.

Join the Waitlist and help shape the future of microbiome medicine.